Zacks Investment Research on MSN

Why is Cytokinetics (CYTK) up 10.4% since last earnings report?

A month has gone by since the last earnings report for Cytokinetics (CYTK). Shares have added about 10.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading ...
pharmaphorum

Update: FDA clears first generic of AZ's blockbuster Symbicort

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
pharmaphorum

FDA starts review of Lantheus’ generic Lutathera

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
Nature

Drug screening articles from across Nature Portfolio

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...
The New York Times

Drug Abuse and Traffic

A former secretary of homeland security on the illegality of Trump’s boat strikes. By Jeh C. Johnson Una encuesta entre 5000 usuarios reveló que más del 60 por ciento lo utiliza para la ansiedad. La ...